We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.57%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$24.2B
AUM Growth
+$1.8B
(+8.1%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
8.1%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
1,081
New
153
Increased
475
Reduced
286
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Energy
CEG
|
+$196M |
| 2 |
JB Hunt Transport Services
JBHT
|
+$148M |
| 3 |
Amphenol
APH
|
+$143M |
| 4 |
Meta Platforms (Facebook)
META
|
+$123M |
| 5 |
Intuit
INTU
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$134M |
| 2 |
Mastercard
MA
|
+$112M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
NVIDIA
NVDA
|
+$94.9M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$93.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.44% |
| 2 | Financials | 13.67% |
| 3 | Consumer Discretionary | 12.77% |
| 4 | Industrials | 11.01% |
| 5 | Healthcare | 10.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
676
DELISTED
Esperion Therapeutics
ESPR
| $1.32M | 0.01% |
595,016
-109,081
| -15% | -$257K |
|
677
Gossamer Bio
GOSS
$94.1M
| $1.3M | 0.01% |
1,444,617
-189,467
| -12% | -$142K |
|
678
Northrim BanCorp
NRIM
$596M
| $1.3M | 0.01% |
90,092
-3,512
| -4% | -$45.3K |
|
|
NFBK
679
DELISTED
Northfield Bancorp
NFBK
| $1.28M | 0.01% |
135,064
+89,571
| +197% | +$785K |
|
|
BLD
680
DELISTED
TopBuild
BLD
| $1.28M | 0.01% |
+3,318
| New | +$1.35M |
|
681
Core Molding Technologies
CMT
$212M
| $1.27M | 0.01% |
79,977
+3,656
| +5% | +$66.8K |
|
682
Central Pacific Financial
CPF
$1.01B
| $1.27M | 0.01% |
59,893
+11,542
| +24% | +$233K |
|
683
Universal Electronics
UEIC
$57.5M
| $1.27M | 0.01% |
109,200
-23,046
| -17% | -$259K |
|
684
Expensify
EXFY
$174M
| $1.26M | 0.01% |
848,672
-103,815
| -11% | -$164K |
|
|
TRUE
685
DELISTED
TrueCar
TRUE
| $1.26M | 0.01% |
403,784
+22,960
| +6% | +$67.3K |
|
686
PMV Pharmaceuticals
PMVP
$62.9M
| $1.26M | 0.01% |
779,025
-47,679
| -6% | -$86K |
|
687
American Well
AMWL
$186M
| $1.25M | 0.01% |
192,840
+87,505
| +83% | +$881K |
|
688
Allient
ALNT
$1.45B
| $1.24M | 0.01% |
49,084
+11,756
| +31% | +$337K |
|
689
Varonis Systems
VRNS
$5.33B
| $1.22M | 0.01% |
25,408
| – | – |
|
690
The RMR Group
RMR
$346M
| $1.21M | 0.01% |
53,505
-23,827
| -31% | -$557K |
|
691
Skyworks Solutions
SWKS
$9.4B
| $1.2M | 0.01% |
11,295
+2,706
| +32% | +$267K |
|
692
Organogenesis Holdings
ORGO
$333M
| $1.2M | 0.01% |
429,804
+243,568
| +131% | +$654K |
|
693
Vera Bradley
VRA
$108M
| $1.2M | 0.01% |
191,901
+9,740
| +5% | +$67.8K |
|
694
AnaptysBio
ANAB
$1.6B
| $1.18M | ﹤0.01% |
47,203
-2,186
| -4% | -$50.9K |
|
695
Kosmos Energy
KOS
$1.45B
| $1.18M | ﹤0.01% |
212,950
-665,089
| -76% | -$3.88M |
|
696
Helios Technologies
HLIO
$2.56B
| $1.18M | ﹤0.01% |
24,676
-55,810
| -69% | -$2.67M |
|
|
TSE
697
DELISTED
Trinseo
TSE
| $1.17M | ﹤0.01% |
507,047
-275,564
| -35% | -$858K |
|
698
Ceco Environmental
CECO
$4.14B
| $1.17M | ﹤0.01% |
40,498
| – | – |
|
699
Markel Group
MKL
$25.3B
| $1.15M | ﹤0.01% |
+729
| New | +$1.13M |
|
700
Donegal Group Class A
DGICA
$709M
| $1.15M | ﹤0.01% |
89,093
+13,260
| +17% | +$176K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2024 Portfolio in Review
As of Q2 2024, Jacobs Levy Equity Management held 1,081 positions worth $24.2B, up 8.1% from $22.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jacobs Levy Equity Management deployed $1.96B of net new capital in Q2 2024, opening 153 new positions and adding to 475 existing holdings. Its largest new stake was Constellation Energy: 961,483 shares worth $193M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Incyte, an estimated $134M trimmed.
- Jacobs Levy Equity Management's largest Q2 2024 buy was Constellation Energy: 961,483 shares worth $193M.
- Jacobs Levy Equity Management added most to JB Hunt Transport Services in Q2 2024, an estimated $148M increase.
- Jacobs Levy Equity Management's biggest Q2 2024 reduction was Incyte, cutting an estimated $134M.
- Jacobs Levy Equity Management fully exited Zscaler in Q2 2024, selling an estimated $38.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 25% of its $24.2B portfolio in Q2 2024.
- Jacobs Levy Equity Management opened 153 new positions and closed 135 in Q2 2024.
- Jacobs Levy Equity Management's portfolio value rose 8.1% quarter-over-quarter to $24.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2024, filed 14 Aug 2024.